Gossamer Bio Inc.

NASDAQ: GOSS · Real-Time Price · USD
1.97
0.01 (0.51%)
At close: Aug 15, 2025, 3:59 PM
1.95
-0.76%
After-hours: Aug 15, 2025, 07:44 PM EDT

Gossamer Bio Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
11.49M 9.89M 9.38M 9.48M 95.84M n/a 6.78M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
n/a n/a n/a n/a n/a 986K 1.01M 1.1M 1.15M n/a 1.12M 1.11M 1.1M 1.1M 1.28M 1.31M 1.3M 1.27M
Gross Profit
11.49M 9.89M 9.38M 9.48M 95.84M -986K 5.78M -1.1M -1.15M n/a -1.12M -1.11M -1.1M -1.1M -1.28M -1.31M -1.3M -1.27M
Operating Income
-38.77M -36.81M -36.13M -33.92M 52.09M -41.96M -49.03M -40.49M -46.3M -47.94M -54.36M -56.02M -53.87M -54.34M -51.66M -55.66M -55.6M -53.2M
Interest Income
542K 294K n/a 430K 1.75M 344K 310K 405K 695K 587K 594K 465K 300K 224K 236K 191K 141K 193K
Pretax Income
-38.27M -36.64M -35.44M -31.93M 53.67M -41.93M -48.15M -40.01M -42.5M -49.16M -55.76M -59.36M -56.47M -57.78M -56.28M -60.25M -59.83M -57.64M
Net Income
-38.27M -36.64M -33.03M -30.8M 49.23M -41.93M -48.15M -40.01M -42.5M -49.16M -57.19M -62.7M -59.06M -61.23M -56.28M -60.25M -59.83M -57.64M
Selling & General & Admin
8.68M 8.66M 9.39M 8.5M 8.67M 9.57M 9.06M 9.29M 9.98M 10.13M 12.83M 11.5M 11.28M 12M 10.71M 12.46M 11.26M 11.35M
Research & Development
41.58M 38.04M 36.11M 34.9M 35.09M 32.39M 29.97M 31.2M 36.31M 37.8M 41.51M 44.51M 42.58M 42.32M 40.93M 43.19M 44.32M 41.83M
Other Expenses
n/a n/a n/a n/a n/a n/a 10M n/a 15K 15K 1.46M -332K 587K -199K 78K 115K 457K 149K
Operating Expenses
50.25M 46.7M 45.51M 43.4M 43.76M 41.96M 49.03M 40.49M 46.3M 47.94M 54.34M 56.01M 53.86M 54.32M 51.65M 55.65M 55.58M 53.17M
Interest Expense
2.74M 2.75M 2.74M 2.73M 2.92M 3.13M 3.24M 3.34M 3.43M 3.5M 3.46M 3.48M 3.48M 3.47M 4.94M 4.89M 4.83M 4.78M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
50.25M 46.7M 45.51M 43.4M 43.76M 41.96M 49.03M 40.49M 46.3M 47.94M 54.34M 56.01M 53.86M 54.32M 51.65M 55.65M 55.58M 53.17M
Income Tax Expense
n/a n/a -2.41M -1.13M 4.43M n/a n/a n/a n/a n/a 1.42M 3.34M 2.59M 3.44M n/a n/a n/a n/a
Shares Outstanding (Basic)
227.28M 226.82M 226.6M 226.35M 226.22M 225.74M 225.41M 192.88M 95.45M 94.55M 94.28M 91.18M 76.67M 75.89M 75.59M 75M 74.67M 74.09M
Shares Outstanding (Diluted)
227.28M 226.82M 226.6M 226.35M 238.54M 225.74M 225.41M 192.88M 95.45M 94.87M 94.28M 91.18M 76.67M 75.89M 75.59M 75M 74.67M 74.09M
EPS (Basic)
-0.17 -0.16 -0.15 -0.14 0.22 -0.19 -0.21 -0.21 -0.45 -0.52 -0.61 -0.69 -0.77 -0.81 -0.74 -0.8 -0.8 -0.78
EPS (Diluted)
-0.17 -0.16 -0.15 -0.14 0.21 -0.19 -0.21 -0.21 -0.45 -0.52 -0.61 -0.69 -0.77 -0.81 -0.74 -0.8 -0.8 -0.78
EBITDA
-35.32M -33.55M -31.63M -28.1M 57.58M -37.81M -43.9M -35.58M -37.92M -44.52M -51.18M -54.78M -51.89M -53.22M -50.06M -54.04M -53.7M -51.59M
EBIT
-35.53M -33.89M -32.7M -29.2M 56.58M -38.8M -44.91M -36.66M -39.07M -45.66M -52.31M -55.89M -52.98M -54.32M -51.35M -55.36M -55M -52.86M
Depreciation & Amortization
213K 342K 1.07M 1.1M 992K 986K 1.01M 1.09M 1.15M 1.14M 1.12M 1.11M 1.1M 1.1M 1.28M 1.31M 1.3M 1.27M